Long-term Visual Outcomes and Causes of Vision Loss in Chronic Central Serous Chorioretinopathy
To evaluate the long-term visual outcomes and causes of vision loss in chronic central serous chorioretinopathy (CSC). Retrospective, longitudinal study. A total of 133 participants (217 eyes) with chronic CSC. A retrospective review of clinical and multimodal imaging data of patients with chronic C...
Saved in:
Published in | Ophthalmology (Rochester, Minn.) Vol. 126; no. 4; pp. 576 - 588 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.04.2019
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | To evaluate the long-term visual outcomes and causes of vision loss in chronic central serous chorioretinopathy (CSC).
Retrospective, longitudinal study.
A total of 133 participants (217 eyes) with chronic CSC.
A retrospective review of clinical and multimodal imaging data of patients with chronic CSC managed by 3 of the authors between May 1977 and March 2018. Multimodal imaging comprised color photography, fluorescein angiography, indocyanine green angiography, fundus autofluorescence (FAF), and OCT.
Best-corrected visual acuity (BCVA) at the final visit; change in BCVA between first visit and 1-, 5-, and 10-year follow-up visits; and causes of vision loss at final visit.
Data from 6228 individual clinic visits were analyzed. Mean age of patients at the first visit was 60.7 years, and mean period of follow-up from first to last visit was 11.3 years. The cohort included 101 male patients (75.9%). At the final visit, 106 patients (79.7%) maintained driving-standard vision with BCVA of 20/40 or better in at least 1 eye, and 17 patients (12.8%) were legally blind with BCVA of 20/200 or worse in both eyes. Mean BCVA at first visit was not significantly different from mean BCVA at 1- or 5-year follow-up visits (both P ≥ 0.65) but was significantly better than the mean BCVA at the 10-year follow-up visit (P = 0.04). Seventy-nine percent of eyes with 20/40 or better vision at the first visit maintained the same level of vision at the 10-year follow-up visit. Ninety-two percent of eyes with 20/200 or worse vision at the first visit maintained the same level of vision at the 10-year follow-up visit. Cystoid macular degeneration, choroidal neovascularization (CNV), outer retinal disruption on OCT, and FAF changes were associated with poorer vision at the final visit (all P ≤ 0.001). Multivariable analysis revealed that greater age at first visit was associated with greater BCVA change at the 10-year follow-up visit (P = 0.001).
Chronic CSC can be a sight-threatening disease leading to legal blindness. Age at presentation and outer retinal changes on multimodal imaging were associated with long-term BCVA changes and may be predictors of long-term visual outcomes. |
---|---|
AbstractList | To evaluate the long-term visual outcomes and causes of vision loss in chronic central serous chorioretinopathy (CSC).
Retrospective, longitudinal study.
A total of 133 participants (217 eyes) with chronic CSC.
A retrospective review of clinical and multimodal imaging data of patients with chronic CSC managed by 3 of the authors between May 1977 and March 2018. Multimodal imaging comprised color photography, fluorescein angiography, indocyanine green angiography, fundus autofluorescence (FAF), and OCT.
Best-corrected visual acuity (BCVA) at the final visit; change in BCVA between first visit and 1-, 5-, and 10-year follow-up visits; and causes of vision loss at final visit.
Data from 6228 individual clinic visits were analyzed. Mean age of patients at the first visit was 60.7 years, and mean period of follow-up from first to last visit was 11.3 years. The cohort included 101 male patients (75.9%). At the final visit, 106 patients (79.7%) maintained driving-standard vision with BCVA of 20/40 or better in at least 1 eye, and 17 patients (12.8%) were legally blind with BCVA of 20/200 or worse in both eyes. Mean BCVA at first visit was not significantly different from mean BCVA at 1- or 5-year follow-up visits (both P ≥ 0.65) but was significantly better than the mean BCVA at the 10-year follow-up visit (P = 0.04). Seventy-nine percent of eyes with 20/40 or better vision at the first visit maintained the same level of vision at the 10-year follow-up visit. Ninety-two percent of eyes with 20/200 or worse vision at the first visit maintained the same level of vision at the 10-year follow-up visit. Cystoid macular degeneration, choroidal neovascularization (CNV), outer retinal disruption on OCT, and FAF changes were associated with poorer vision at the final visit (all P ≤ 0.001). Multivariable analysis revealed that greater age at first visit was associated with greater BCVA change at the 10-year follow-up visit (P = 0.001).
Chronic CSC can be a sight-threatening disease leading to legal blindness. Age at presentation and outer retinal changes on multimodal imaging were associated with long-term BCVA changes and may be predictors of long-term visual outcomes. PURPOSETo evaluate the long-term visual outcomes and causes of vision loss in chronic central serous chorioretinopathy (CSC). DESIGNRetrospective, longitudinal study. PARTICIPANTSA total of 133 participants (217 eyes) with chronic CSC. METHODSA retrospective review of clinical and multimodal imaging data of patients with chronic CSC managed by 3 of the authors between May 1977 and March 2018. Multimodal imaging comprised color photography, fluorescein angiography, indocyanine green angiography, fundus autofluorescence (FAF), and OCT. MAIN OUTCOME MEASURESBest-corrected visual acuity (BCVA) at the final visit; change in BCVA between first visit and 1-, 5-, and 10-year follow-up visits; and causes of vision loss at final visit. RESULTSData from 6228 individual clinic visits were analyzed. Mean age of patients at the first visit was 60.7 years, and mean period of follow-up from first to last visit was 11.3 years. The cohort included 101 male patients (75.9%). At the final visit, 106 patients (79.7%) maintained driving-standard vision with BCVA of 20/40 or better in at least 1 eye, and 17 patients (12.8%) were legally blind with BCVA of 20/200 or worse in both eyes. Mean BCVA at first visit was not significantly different from mean BCVA at 1- or 5-year follow-up visits (both P ≥ 0.65) but was significantly better than the mean BCVA at the 10-year follow-up visit (P = 0.04). Seventy-nine percent of eyes with 20/40 or better vision at the first visit maintained the same level of vision at the 10-year follow-up visit. Ninety-two percent of eyes with 20/200 or worse vision at the first visit maintained the same level of vision at the 10-year follow-up visit. Cystoid macular degeneration, choroidal neovascularization (CNV), outer retinal disruption on OCT, and FAF changes were associated with poorer vision at the final visit (all P ≤ 0.001). Multivariable analysis revealed that greater age at first visit was associated with greater BCVA change at the 10-year follow-up visit (P = 0.001). CONCLUSIONSChronic CSC can be a sight-threatening disease leading to legal blindness. Age at presentation and outer retinal changes on multimodal imaging were associated with long-term BCVA changes and may be predictors of long-term visual outcomes. |
Author | Dansingani, Kunal Balaratnasingam, Chandrakumar Bhavsar, Kavita V. Yannuzzi, Lawrence A. Spaide, Richard F. Stoffels, Guillaume Yu, Suqin Mrejen, Sarah Bottini, Alexander Patel, Samir Kaden, Talia R. Freund, K. Bailey Chen, Kevin C. Yannuzzi, Nicolas A. |
Author_xml | – sequence: 1 givenname: Sarah surname: Mrejen fullname: Mrejen, Sarah email: sarahmrejen.uretsky@gmail.com organization: Vitreous, Retina, Macula Consultants of New York, New York – sequence: 2 givenname: Chandrakumar surname: Balaratnasingam fullname: Balaratnasingam, Chandrakumar organization: Vitreous, Retina, Macula Consultants of New York, New York – sequence: 3 givenname: Talia R. surname: Kaden fullname: Kaden, Talia R. organization: Vitreous, Retina, Macula Consultants of New York, New York – sequence: 4 givenname: Alexander surname: Bottini fullname: Bottini, Alexander organization: Department of Ophthalmology, New York University School of Medicine, New York, New York – sequence: 5 givenname: Kunal orcidid: 0000-0002-7430-8601 surname: Dansingani fullname: Dansingani, Kunal organization: Vitreous, Retina, Macula Consultants of New York, New York – sequence: 6 givenname: Kavita V. surname: Bhavsar fullname: Bhavsar, Kavita V. organization: Vitreous, Retina, Macula Consultants of New York, New York – sequence: 7 givenname: Nicolas A. surname: Yannuzzi fullname: Yannuzzi, Nicolas A. organization: Department of Ophthalmology, Bascolm Palmer Eye Institute, Miami, Florida – sequence: 8 givenname: Samir orcidid: 0000-0002-3050-9129 surname: Patel fullname: Patel, Samir organization: Department of Ophthalmology, Wills Eye Hospital, Philadelphia, Pennsylvania – sequence: 9 givenname: Kevin C. orcidid: 0000-0002-8364-4033 surname: Chen fullname: Chen, Kevin C. organization: Department of Ophthalmology, New York University School of Medicine, New York, New York – sequence: 10 givenname: Suqin surname: Yu fullname: Yu, Suqin organization: Vitreous, Retina, Macula Consultants of New York, New York – sequence: 11 givenname: Guillaume surname: Stoffels fullname: Stoffels, Guillaume organization: Biostatistics Unit of Feinstein Institute for Medical Research, New York – sequence: 12 givenname: Richard F. surname: Spaide fullname: Spaide, Richard F. organization: Vitreous, Retina, Macula Consultants of New York, New York – sequence: 13 givenname: K. Bailey orcidid: 0000-0002-7888-9773 surname: Freund fullname: Freund, K. Bailey organization: Vitreous, Retina, Macula Consultants of New York, New York – sequence: 14 givenname: Lawrence A. surname: Yannuzzi fullname: Yannuzzi, Lawrence A. organization: Vitreous, Retina, Macula Consultants of New York, New York |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30659849$$D View this record in MEDLINE/PubMed https://hal.science/hal-03486015$$DView record in HAL |
BookMark | eNp9kctu1TAQhi1URE8Lb4BQlrBI8DWON0hVBBQpUhdctpbrTIiPEvtgO5X69vgopUtWMxp__4xn_it04YMHhN4S3BBM2o_HJpzmPJuGYtI1hDaYdy_QgQiuai4Ju0CHgpG65RRfoquUjhjjtmX8FbpkuBWq4-qA9BD87zpDXKtfLm1mqe62bMMKqTJ-rHqzpZKG6fzqgq-GkFLlfNXPMXhnqx58jkX1HWLYUimH6EKE7Hw4mTw_vkYvJ7MkePMUr9HPL59_9Lf1cPf1W38z1FbgLtdGUUvINHEmrVAcA7s3vCPUUNlSrNgoQXQwKpiMEgJbiUfOLVdEytEKjtk1-rD3nc2iT9GtJj7qYJy-vRn0uYYZ71pMxAMp7PudPcXwZ4OU9eqShWUxHsoSmhJZvsAJkwXlO2pjWTzC9NybYH22QR_1boM-26AJ1cWGInv3NGG7X2F8Fv27ewE-7QCUmzw4iDpZB97C6CLYrMfg_j_hL16vm3w |
CitedBy_id | crossref_primary_10_3390_ph14020105 crossref_primary_10_1007_s10633_022_09895_7 crossref_primary_10_1038_s41433_021_01778_6 crossref_primary_10_1097_MD_0000000000027069 crossref_primary_10_1016_j_preteyeres_2020_100865 crossref_primary_10_1016_j_ajo_2021_05_029 crossref_primary_10_1016_j_preteyeres_2019_07_003 crossref_primary_10_1016_j_ophtha_2018_11_012 crossref_primary_10_1007_s00417_022_05924_y crossref_primary_10_18008_1816_5095_2023_2_221_227 crossref_primary_10_1038_s41598_022_14777_8 crossref_primary_10_1177_11206721221137153 crossref_primary_10_1016_j_ajo_2023_05_022 crossref_primary_10_1136_bjophthalmol_2020_317422 crossref_primary_10_1007_s00417_023_06185_z crossref_primary_10_1007_s10103_020_03129_5 crossref_primary_10_1016_j_xops_2021_100071 crossref_primary_10_1007_s10103_024_04030_1 crossref_primary_10_3390_ph14010026 crossref_primary_10_1038_s41433_021_01762_0 crossref_primary_10_3390_genes13010055 crossref_primary_10_1007_s10384_021_00815_x crossref_primary_10_1186_s12886_022_02330_0 crossref_primary_10_1111_ceo_14201 crossref_primary_10_1016_j_oret_2020_07_026 crossref_primary_10_1016_j_oret_2023_10_024 crossref_primary_10_1155_2021_9929864 crossref_primary_10_1038_s41433_020_01345_5 crossref_primary_10_1016_j_oftal_2020_07_023 crossref_primary_10_1038_s42003_019_0712_z crossref_primary_10_3390_diagnostics13172792 crossref_primary_10_1097_IAE_0000000000002810 crossref_primary_10_1167_tvst_12_12_17 crossref_primary_10_1097_APO_0000000000000584 crossref_primary_10_3390_jcm10051087 crossref_primary_10_7759_cureus_46100 crossref_primary_10_1155_2019_5970659 crossref_primary_10_1167_iovs_64_13_28 crossref_primary_10_1007_s00417_020_04959_3 crossref_primary_10_1155_2021_9952050 crossref_primary_10_3390_life13051194 crossref_primary_10_1097_IAE_0000000000002791 crossref_primary_10_3928_23258160_20200702_07 crossref_primary_10_1007_s00401_023_02628_3 crossref_primary_10_1038_s41598_023_41126_0 crossref_primary_10_1097_IAE_0000000000003363 crossref_primary_10_1016_j_ophtha_2022_04_018 crossref_primary_10_1007_s10384_022_00945_w crossref_primary_10_1097_ICB_0000000000001380 crossref_primary_10_1097_IAE_0000000000003876 crossref_primary_10_1177_11206721211064021 crossref_primary_10_1080_08820538_2024_2373268 crossref_primary_10_1111_aos_15194 crossref_primary_10_1161_ATVBAHA_122_318151 crossref_primary_10_1016_j_ajo_2024_01_025 crossref_primary_10_3341_kjo_2023_0005 crossref_primary_10_1016_j_pdpdt_2022_103126 crossref_primary_10_1089_jop_2023_0124 crossref_primary_10_1038_s41433_021_01788_4 crossref_primary_10_1111_aos_14775 crossref_primary_10_1111_aos_16679 crossref_primary_10_1016_j_oret_2022_04_014 crossref_primary_10_1080_09273948_2023_2226206 crossref_primary_10_3389_fbioe_2021_651340 crossref_primary_10_1007_s10633_024_09969_8 crossref_primary_10_1177_25158414231160689 crossref_primary_10_1016_j_exer_2019_107754 crossref_primary_10_3390_jcm9113429 crossref_primary_10_3390_ph14010053 crossref_primary_10_1016_j_apjo_2023_100003 crossref_primary_10_1055_a_2227_4037 crossref_primary_10_1097_IIO_0000000000000514 crossref_primary_10_1167_tvst_12_10_12 crossref_primary_10_1097_OPX_0000000000001833 crossref_primary_10_1007_s00417_020_04623_w crossref_primary_10_1038_s41433_020_0802_7 crossref_primary_10_1016_j_oret_2019_08_002 crossref_primary_10_1159_000504053 crossref_primary_10_1016_j_oret_2022_04_004 crossref_primary_10_1136_bmjophth_2022_000976 crossref_primary_10_1007_s10633_022_09875_x crossref_primary_10_1016_j_pdpdt_2023_103501 crossref_primary_10_1007_s00417_021_05256_3 crossref_primary_10_1007_s10278_023_00926_6 crossref_primary_10_1038_s41598_023_37802_w crossref_primary_10_1016_j_xops_2022_100152 crossref_primary_10_1186_s12886_022_02472_1 crossref_primary_10_1167_iovs_61_8_50 crossref_primary_10_1080_07853890_2023_2227424 crossref_primary_10_1016_j_ajo_2021_06_020 crossref_primary_10_1167_tvst_10_8_9 crossref_primary_10_1136_bjophthalmol_2021_319403 crossref_primary_10_1016_j_ajo_2023_04_016 crossref_primary_10_1007_s00417_022_05836_x crossref_primary_10_1186_s40942_022_00400_5 crossref_primary_10_1016_j_pdpdt_2021_102410 crossref_primary_10_1038_s41598_021_82650_1 crossref_primary_10_3928_23258160_20210528_02 crossref_primary_10_1038_s41598_020_73959_4 crossref_primary_10_17116_oftalma202313904165 crossref_primary_10_3389_fmed_2021_687023 crossref_primary_10_1016_j_pdpdt_2023_103576 crossref_primary_10_3389_fphys_2021_649316 crossref_primary_10_1097_IAE_0000000000003157 crossref_primary_10_1016_j_preteyeres_2022_101092 crossref_primary_10_1007_s40123_022_00625_5 crossref_primary_10_1007_s00417_022_05636_3 crossref_primary_10_1007_s10103_022_03574_4 crossref_primary_10_1016_j_ajo_2020_10_011 crossref_primary_10_1164_rccm_202001_0093LE crossref_primary_10_1055_a_1531_5605 crossref_primary_10_1038_s41433_020_1018_6 crossref_primary_10_1159_000533910 crossref_primary_10_1186_s12886_021_01980_w crossref_primary_10_1007_s10792_021_01754_9 crossref_primary_10_3390_jcm12093102 crossref_primary_10_1186_s40942_022_00385_1 crossref_primary_10_1186_s40942_021_00342_4 crossref_primary_10_3389_fphar_2024_1200492 crossref_primary_10_7759_cureus_25925 crossref_primary_10_1007_s10792_023_02822_y crossref_primary_10_1038_s41433_022_02044_z crossref_primary_10_1016_j_pdpdt_2021_102235 crossref_primary_10_1038_s41598_024_64524_4 crossref_primary_10_1080_08820538_2021_1900289 crossref_primary_10_12688_f1000research_138162_1 crossref_primary_10_1007_s40123_023_00739_4 crossref_primary_10_1038_s41433_021_01808_3 crossref_primary_10_1038_s41598_020_65370_w crossref_primary_10_1097_MD_0000000000026980 crossref_primary_10_3390_life13061407 crossref_primary_10_1016_j_preteyeres_2021_100955 crossref_primary_10_1016_j_ajo_2021_10_021 crossref_primary_10_1038_s41598_023_49153_7 crossref_primary_10_1167_tvst_9_13_6 crossref_primary_10_1097_IAE_0000000000003692 crossref_primary_10_1136_bjophthalmol_2019_315550 crossref_primary_10_1186_s12886_021_02022_1 crossref_primary_10_1007_s00417_021_05452_1 crossref_primary_10_1097_IAE_0000000000003845 crossref_primary_10_1097_IAE_0000000000003965 crossref_primary_10_1038_s41433_023_02509_9 crossref_primary_10_1097_IAE_0000000000003843 crossref_primary_10_1159_000520187 crossref_primary_10_1007_s40123_023_00687_z crossref_primary_10_1155_2022_1272524 crossref_primary_10_1016_j_ajo_2020_04_007 crossref_primary_10_1016_j_preteyeres_2024_101236 crossref_primary_10_1016_j_oftale_2020_07_005 crossref_primary_10_1159_000510828 crossref_primary_10_1016_j_ajo_2021_02_034 |
Cites_doi | 10.1001/archopht.1991.01080090066027 10.1016/j.ophtha.2005.06.026 10.1097/IAE.0b013e3181be0a83 10.1016/j.ophtha.2010.08.017 10.1016/S0161-6420(89)32810-7 10.1016/S0161-6420(96)30386-2 10.1016/j.ajo.2011.04.008 10.2147/OPTH.S115685 10.1016/S0161-6420(96)30730-6 10.1016/j.ophtha.2016.03.045 10.1016/j.ajo.2003.09.042 10.1016/S0161-6420(01)00951-4 10.1111/j.1442-9071.2006.01447.x 10.1016/S0161-6420(84)34117-3 10.1016/j.ophtha.2007.02.015 10.1016/j.ajo.2016.03.025 10.1016/j.ophtha.2005.01.003 10.1001/jamaophthalmol.2015.1320 10.1016/j.ajo.2015.02.002 10.1016/j.preteyeres.2015.05.003 10.1016/S0161-6420(02)01117-X 10.1016/j.ophtha.2003.09.024 10.1136/bjo.68.11.815 10.1371/journal.pone.0181479 10.1097/IAE.0000000000000529 10.1034/j.1600-0420.2001.079004417.x 10.1097/IAE.0b013e318156db8a 10.1016/j.ophtha.2016.03.017 10.1097/IAE.0b013e3181669504 10.1097/IAE.0b013e3181e7976b 10.1016/j.ophtha.2008.01.021 10.1097/00006982-200202000-00004 10.1097/IAE.0000000000000742 10.1016/j.ophtha.2007.02.032 10.1080/09286586.2016.1259636 10.1097/IAE.0b013e3182680a66 10.1097/00006982-200302000-00001 10.1097/IAE.0b013e3182993f66 10.1097/IAE.0000000000000331 10.1111/j.1600-0420.2005.00442.x |
ContentType | Journal Article |
Copyright | 2019 American Academy of Ophthalmology Copyright © 2019 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. Attribution - NonCommercial |
Copyright_xml | – notice: 2019 American Academy of Ophthalmology – notice: Copyright © 2019 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. – notice: Attribution - NonCommercial |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 1XC VOOES |
DOI | 10.1016/j.ophtha.2018.12.048 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic Hyper Article en Ligne (HAL) Hyper Article en Ligne (HAL) (Open Access) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1549-4713 |
EndPage | 588 |
ExternalDocumentID | oai_HAL_hal_03486015v1 10_1016_j_ophtha_2018_12_048 30659849 S0161642017320675 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K .1- .55 .FO .GJ 0R~ 123 1B1 1P~ 1~5 29N 4.4 457 4G. 53G 5RE 5VS 7-5 71M AAEDT AAEDW AAIAV AALRI AAQFI AAQQT AAQXK AAXUO ABCQX ABFRF ABJNI ABLJU ABMAC ABOCM ACGFO ACGFS ACIUM ACNCT ADMUD ADPAM AEFWE AENEX AEVXI AFFNX AFRHN AFTJW AGZHU AHPSJ AITUG AJUYK ALMA_UNASSIGNED_HOLDINGS ALXNB AMRAJ BELOY C5W CS3 DU5 EBS EFJIC EJD F5P FDB FEDTE FGOYB GBLVA HVGLF HZ~ IHE J1W K-O KOM L7B M27 M41 MO0 N4W N9A NQ- O9- OF- OPF OQ~ P2P R2- RIG ROL RPZ SDG SEL SES SSZ UHS UNMZH UV1 WH7 X7M XH2 XPP Z5R ZA5 ZGI ZXP AFJKZ AKRWK CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 1XC VOOES |
ID | FETCH-LOGICAL-c508t-a92c11ff437c5940e3ba4812a2762093d7e58ed9efa9550c70d44c49177dc5403 |
ISSN | 0161-6420 |
IngestDate | Tue Oct 15 15:31:15 EDT 2024 Sat Aug 17 03:58:56 EDT 2024 Thu Sep 26 16:15:45 EDT 2024 Sat Sep 28 08:34:54 EDT 2024 Fri Feb 23 02:28:30 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | PDT SD OCT D CI RPE VEGF NV CNV FAF VA logMAR PED MPS CSC EZ ICGA CMD FA VRMNY |
Language | English |
License | Copyright © 2019 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. Attribution - NonCommercial: http://creativecommons.org/licenses/by-nc |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c508t-a92c11ff437c5940e3ba4812a2762093d7e58ed9efa9550c70d44c49177dc5403 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-3050-9129 0000-0002-7430-8601 0000-0002-7888-9773 0000-0002-8364-4033 |
OpenAccessLink | https://hal.science/hal-03486015 |
PMID | 30659849 |
PQID | 2179404137 |
PQPubID | 23479 |
PageCount | 13 |
ParticipantIDs | hal_primary_oai_HAL_hal_03486015v1 proquest_miscellaneous_2179404137 crossref_primary_10_1016_j_ophtha_2018_12_048 pubmed_primary_30659849 elsevier_sciencedirect_doi_10_1016_j_ophtha_2018_12_048 |
PublicationCentury | 2000 |
PublicationDate | 2019-04-01 |
PublicationDateYYYYMMDD | 2019-04-01 |
PublicationDate_xml | – month: 04 year: 2019 text: 2019-04-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Ophthalmology (Rochester, Minn.) |
PublicationTitleAlternate | Ophthalmology |
PublicationYear | 2019 |
Publisher | Elsevier Inc Elsevier |
Publisher_xml | – name: Elsevier Inc – name: Elsevier |
References | Ober, Yannuzzi, Do (bib22) 2005; 112 Grossniklaus, Green (bib42) 2004; 137 Bae, Heo, Kim (bib9) 2011; 152 (bib30) 1991; 109 Ying, Maguire, Glynn, Rosner (bib33) 2017; 24 Mudvari, Goff, Fu (bib15) 2007; 27 Haga, Maruko, Sato (bib37) 2017; 12 Mrejen, Sarraf, Mukkamala, Freund (bib8) 2013; 33 Tsai, Chen, Huang (bib12) 2013; 8 Balaratnasingam, Freund, Tan (bib19) 2016; 123 Daruich, Matet, Dirani (bib1) 2015; 48 Hirami, Tsujikawa, Sasahara (bib14) 2007; 35 Gilbert, Owens, Smith, Fine (bib4) 1984; 68 Yannuzzi, Shakin, Fisher, Altomonte (bib18) 1984; 91 Ojima, Hangai, Sasahara (bib39) 2007; 114 Haimovici, Koh, Gagnon (bib2) 2004; 111 Maguire, Martin (bib38) 2016; 123 Levine, Brucker, Robinson (bib5) 1989; 96 Hosmer, Lemeshow (bib34) 2013 Bonini Filho, de Carlo, Ferrara (bib41) 2015; 133 Bujarborua (bib7) 2001; 79 Iida, Yannuzzi, Spaide (bib25) 2003; 23 Freund, Ho, Barbazetto (bib27) 2008; 28 Dansingani, Balaratnasingam, Naysan, Freund (bib16) 2016; 36 Dansingani, Balaratnasingam, Mrejen (bib20) 2016; 166 Imamura, Fujiwara, Margolis, Spaide (bib17) 2009; 29 Perkins, Kim, Pollack, Merrill (bib43) 2002; 109 Spaide, Campeas, Haas (bib3) 1996; 103 Peiretti, Ferrara, Caminiti (bib40) 2015; 35 Carvalho-Recchia, Yannuzzi, Negrao (bib11) 2002; 109 Yannuzzi (bib13) 1986; 84 Fujimoto, Gomi, Wakabayashi (bib10) 2008; 115 Breukink, Dingemans, den Hollander (bib36) 2017; 11 Imamura, Fujiwara, Spaide (bib21) 2011; 118 Loo, Scott, Flynn (bib6) 2002; 22 Hage, Mrejen, Krivosic (bib31) 2015; 159 Freund, Zweifel, Engelbert (bib28) 2010; 30 Gass (bib29) 2012 Spaide, Klancnik (bib23) 2005; 112 Kitzmann, Pulido, Diehl (bib35) 2008; 115 Pang, Freund (bib26) 2015; 35 Fung, Yannuzzi, Freund (bib24) 2012; 32 Framme, Walter, Gabler (bib32) 2005; 83 Quillen, Gass, Brod (bib44) 1996; 103 30910041 - Ophthalmology. 2019 Apr;126(4):589-590 Ojima (10.1016/j.ophtha.2018.12.048_bib39) 2007; 114 Bujarborua (10.1016/j.ophtha.2018.12.048_bib7) 2001; 79 Bae (10.1016/j.ophtha.2018.12.048_bib9) 2011; 152 Bonini Filho (10.1016/j.ophtha.2018.12.048_bib41) 2015; 133 Mudvari (10.1016/j.ophtha.2018.12.048_bib15) 2007; 27 Balaratnasingam (10.1016/j.ophtha.2018.12.048_bib19) 2016; 123 Dansingani (10.1016/j.ophtha.2018.12.048_bib20) 2016; 166 Spaide (10.1016/j.ophtha.2018.12.048_bib3) 1996; 103 Haimovici (10.1016/j.ophtha.2018.12.048_bib2) 2004; 111 Iida (10.1016/j.ophtha.2018.12.048_bib25) 2003; 23 Spaide (10.1016/j.ophtha.2018.12.048_bib23) 2005; 112 Imamura (10.1016/j.ophtha.2018.12.048_bib17) 2009; 29 Pang (10.1016/j.ophtha.2018.12.048_bib26) 2015; 35 Ying (10.1016/j.ophtha.2018.12.048_bib33) 2017; 24 Ober (10.1016/j.ophtha.2018.12.048_bib22) 2005; 112 Peiretti (10.1016/j.ophtha.2018.12.048_bib40) 2015; 35 Perkins (10.1016/j.ophtha.2018.12.048_bib43) 2002; 109 Hirami (10.1016/j.ophtha.2018.12.048_bib14) 2007; 35 Imamura (10.1016/j.ophtha.2018.12.048_bib21) 2011; 118 Gass (10.1016/j.ophtha.2018.12.048_bib29) 2012 Breukink (10.1016/j.ophtha.2018.12.048_bib36) 2017; 11 Hage (10.1016/j.ophtha.2018.12.048_bib31) 2015; 159 Loo (10.1016/j.ophtha.2018.12.048_bib6) 2002; 22 Freund (10.1016/j.ophtha.2018.12.048_bib28) 2010; 30 Dansingani (10.1016/j.ophtha.2018.12.048_bib16) 2016; 36 Hosmer (10.1016/j.ophtha.2018.12.048_bib34) 2013 (10.1016/j.ophtha.2018.12.048_bib30) 1991; 109 Grossniklaus (10.1016/j.ophtha.2018.12.048_bib42) 2004; 137 Kitzmann (10.1016/j.ophtha.2018.12.048_bib35) 2008; 115 Mrejen (10.1016/j.ophtha.2018.12.048_bib8) 2013; 33 Maguire (10.1016/j.ophtha.2018.12.048_bib38) 2016; 123 Carvalho-Recchia (10.1016/j.ophtha.2018.12.048_bib11) 2002; 109 Tsai (10.1016/j.ophtha.2018.12.048_bib12) 2013; 8 Fung (10.1016/j.ophtha.2018.12.048_bib24) 2012; 32 Quillen (10.1016/j.ophtha.2018.12.048_bib44) 1996; 103 Framme (10.1016/j.ophtha.2018.12.048_bib32) 2005; 83 Fujimoto (10.1016/j.ophtha.2018.12.048_bib10) 2008; 115 Yannuzzi (10.1016/j.ophtha.2018.12.048_bib13) 1986; 84 Yannuzzi (10.1016/j.ophtha.2018.12.048_bib18) 1984; 91 Freund (10.1016/j.ophtha.2018.12.048_bib27) 2008; 28 Daruich (10.1016/j.ophtha.2018.12.048_bib1) 2015; 48 Haga (10.1016/j.ophtha.2018.12.048_bib37) 2017; 12 Gilbert (10.1016/j.ophtha.2018.12.048_bib4) 1984; 68 Levine (10.1016/j.ophtha.2018.12.048_bib5) 1989; 96 |
References_xml | – volume: 137 start-page: 496 year: 2004 end-page: 503 ident: bib42 article-title: Choroidal neovascularization publication-title: Am J Ophthalmol contributor: fullname: Green – volume: 32 start-page: 1829 year: 2012 end-page: 1837 ident: bib24 article-title: Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration publication-title: Retina contributor: fullname: Freund – volume: 11 start-page: 39 year: 2017 end-page: 46 ident: bib36 article-title: Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life publication-title: Clin Ophthalmol contributor: fullname: den Hollander – volume: 111 start-page: 244 year: 2004 end-page: 249 ident: bib2 article-title: Risk factors for central serous chorioretinopathy: a case-control study publication-title: Ophthalmology contributor: fullname: Gagnon – volume: 8 year: 2013 ident: bib12 article-title: Epidemiology of idiopathic central serous chorioretinopathy in Taiwan, 2001-2006: a population-based study publication-title: PLoS One contributor: fullname: Huang – volume: 23 start-page: 1 year: 2003 end-page: 7 ident: bib25 article-title: Cystoid macular degeneration in chronic central serous chorioretinopathy publication-title: Retina contributor: fullname: Spaide – year: 2013 ident: bib34 article-title: Applied Logistic Regression contributor: fullname: Lemeshow – volume: 33 start-page: 1735 year: 2013 end-page: 1762 ident: bib8 article-title: Multimodal imaging of pigment epithelial detachment: a guide to evaluation publication-title: Retina contributor: fullname: Freund – volume: 112 start-page: 825 year: 2005 end-page: 833 ident: bib23 article-title: Fundus autofluorescence and central serous chorioretinopathy publication-title: Ophthalmology contributor: fullname: Klancnik – volume: 35 start-page: 225 year: 2007 end-page: 230 ident: bib14 article-title: Alterations of retinal pigment epithelium in central serous chorioretinopathy publication-title: Clin Exp Ophthalmol contributor: fullname: Sasahara – volume: 48 start-page: 82 year: 2015 end-page: 118 ident: bib1 article-title: Central serous chorioretinopathy: recent findings and new physiopathology hypothesis publication-title: Prog Retin Eye Res contributor: fullname: Dirani – volume: 112 start-page: 2088 year: 2005 end-page: 2094 ident: bib22 article-title: Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy publication-title: Ophthalmology contributor: fullname: Do – volume: 22 start-page: 19 year: 2002 end-page: 24 ident: bib6 article-title: Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy publication-title: Retina contributor: fullname: Flynn – volume: 123 start-page: 1751 year: 2016 end-page: 1761 ident: bib38 article-title: Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: the Comparison of Age-related macular degeneration Treatments Trials publication-title: Ophthalmology contributor: fullname: Martin – volume: 96 start-page: 854 year: 1989 end-page: 859 ident: bib5 article-title: Long-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography publication-title: Ophthalmology contributor: fullname: Robinson – volume: 68 start-page: 815 year: 1984 end-page: 820 ident: bib4 article-title: Long-term follow-up of central serous chorioretinopathy publication-title: Br J Ophthalmol contributor: fullname: Fine – volume: 109 start-page: 1834 year: 2002 end-page: 1837 ident: bib11 article-title: Corticosteroids and central serous chorioretinopathy publication-title: Ophthalmology contributor: fullname: Negrao – volume: 115 start-page: 169 year: 2008 end-page: 173 ident: bib35 article-title: The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002 publication-title: Ophthalmology contributor: fullname: Diehl – volume: 29 start-page: 1469 year: 2009 end-page: 1473 ident: bib17 article-title: Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy publication-title: Retina contributor: fullname: Spaide – volume: 166 start-page: 60 year: 2016 end-page: 67 ident: bib20 article-title: Annular lesions and catenary forms in chronic central serous chorioretinopathy publication-title: Am J Ophthalmol contributor: fullname: Mrejen – volume: 109 start-page: 1242 year: 1991 end-page: 1257 ident: bib30 article-title: Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Macular Photocoagulation Study Group publication-title: Arch Ophthalmol – volume: 114 start-page: 2197 year: 2007 end-page: 2207 ident: bib39 article-title: Three-dimensional imaging of the foveal photoreceptor layer in central serous chorioretinopathy using high-speed optical coherence tomography publication-title: Ophthalmology contributor: fullname: Sasahara – volume: 84 start-page: 799 year: 1986 end-page: 845 ident: bib13 article-title: Type A behavior and central serous chorioretinopathy publication-title: Trans Am Ophthalmol Soc contributor: fullname: Yannuzzi – volume: 35 start-page: 1 year: 2015 end-page: 9 ident: bib26 article-title: Pachychoroid neovasculopathy publication-title: Retina contributor: fullname: Freund – volume: 133 start-page: 899 year: 2015 end-page: 906 ident: bib41 article-title: Association of choroidal neovascularization and central serous chorioretinopathy with optical coherence tomography angiography publication-title: JAMA Ophthalmol contributor: fullname: Ferrara – volume: 118 start-page: 700 year: 2011 end-page: 705 ident: bib21 article-title: Fundus autofluorescence and visual acuity in central serous chorioretinopathy publication-title: Ophthalmology contributor: fullname: Spaide – volume: 115 start-page: 1494 year: 2008 end-page: 1500 ident: bib10 article-title: Morphologic changes in acute central serous chorioretinopathy evaluated by Fourier-domain optical coherence tomography publication-title: Ophthalmology contributor: fullname: Wakabayashi – volume: 30 start-page: 1333 year: 2010 end-page: 1349 ident: bib28 article-title: Do we need a new classification for choroidal neovascularization in age-related macular degeneration? publication-title: Retina contributor: fullname: Engelbert – volume: 27 start-page: 1168 year: 2007 end-page: 1173 ident: bib15 article-title: The natural history of pigment epithelial detachment associated with central serous chorioretinopathy publication-title: Retina contributor: fullname: Fu – volume: 79 start-page: 417 year: 2001 end-page: 421 ident: bib7 article-title: Long-term follow-up of idiopathic central serous chorioretinopathy without laser publication-title: Acta Ophthalmol Scand contributor: fullname: Bujarborua – volume: 152 start-page: 784 year: 2011 end-page: 792.e782 ident: bib9 article-title: A randomized pilot study of low-fluence photodynamic therapy versus intravitreal ranibizumab for chronic central serous chorioretinopathy publication-title: Am J Ophthalmol contributor: fullname: Kim – volume: 36 start-page: 499 year: 2016 end-page: 516 ident: bib16 article-title: En face imaging of pachychoroid spectrum disorders with swept-source optical coherence tomography publication-title: Retina contributor: fullname: Freund – volume: 103 start-page: 72 year: 1996 end-page: 79 ident: bib44 article-title: Central serous chorioretinopathy in women publication-title: Ophthalmology contributor: fullname: Brod – volume: 91 start-page: 1554 year: 1984 end-page: 1572 ident: bib18 article-title: Peripheral retinal detachments and retinal pigment epithelial atrophic tracts secondary to central serous pigment epitheliopathy publication-title: Ophthalmology contributor: fullname: Altomonte – volume: 109 start-page: 262 year: 2002 end-page: 266 ident: bib43 article-title: Clinical characteristics of central serous chorioretinopathy in women publication-title: Ophthalmology contributor: fullname: Merrill – year: 2012 ident: bib29 article-title: Atlas of Macular Diseases. contributor: fullname: Gass – volume: 24 start-page: 130 year: 2017 end-page: 140 ident: bib33 article-title: Tutorial on biostatistics: linear regression analysis of continuous correlated eye data publication-title: Ophthalmic Epidemiol contributor: fullname: Rosner – volume: 83 start-page: 161 year: 2005 end-page: 167 ident: bib32 article-title: Fundus autofluorescence in acute and chronic-recurrent central serous chorioretinopathy publication-title: Acta Ophthalmol Scand contributor: fullname: Gabler – volume: 28 start-page: 201 year: 2008 end-page: 211 ident: bib27 article-title: Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation publication-title: Retina contributor: fullname: Barbazetto – volume: 35 start-page: 1360 year: 2015 end-page: 1367 ident: bib40 article-title: Choroidal neovascularization in Caucasian patients with longstanding central serous chorioretinopathy publication-title: Retina contributor: fullname: Caminiti – volume: 123 start-page: 1541 year: 2016 end-page: 1552 ident: bib19 article-title: Bullous variant of central serous chorioretinopathy: expansion of phenotypic features using multimethod imaging publication-title: Ophthalmology contributor: fullname: Tan – volume: 159 start-page: 890 year: 2015 end-page: 903.e893 ident: bib31 article-title: Flat irregular retinal pigment epithelium detachments in chronic central serous chorioretinopathy and choroidal neovascularization publication-title: Am J Ophthalmol contributor: fullname: Krivosic – volume: 103 start-page: 2070 year: 1996 end-page: 2079 ident: bib3 article-title: Central serous chorioretinopathy in younger and older adults publication-title: Ophthalmology contributor: fullname: Haas – volume: 12 year: 2017 ident: bib37 article-title: Long-term prognostic factors of chronic central serous chorioretinopathy after half-dose photodynamic therapy: a 3-year follow-up study publication-title: PLoS One contributor: fullname: Sato – volume: 109 start-page: 1242 year: 1991 ident: 10.1016/j.ophtha.2018.12.048_bib30 article-title: Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Macular Photocoagulation Study Group publication-title: Arch Ophthalmol doi: 10.1001/archopht.1991.01080090066027 – volume: 112 start-page: 2088 year: 2005 ident: 10.1016/j.ophtha.2018.12.048_bib22 article-title: Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy publication-title: Ophthalmology doi: 10.1016/j.ophtha.2005.06.026 contributor: fullname: Ober – volume: 29 start-page: 1469 year: 2009 ident: 10.1016/j.ophtha.2018.12.048_bib17 article-title: Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy publication-title: Retina doi: 10.1097/IAE.0b013e3181be0a83 contributor: fullname: Imamura – volume: 118 start-page: 700 year: 2011 ident: 10.1016/j.ophtha.2018.12.048_bib21 article-title: Fundus autofluorescence and visual acuity in central serous chorioretinopathy publication-title: Ophthalmology doi: 10.1016/j.ophtha.2010.08.017 contributor: fullname: Imamura – volume: 96 start-page: 854 year: 1989 ident: 10.1016/j.ophtha.2018.12.048_bib5 article-title: Long-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography publication-title: Ophthalmology doi: 10.1016/S0161-6420(89)32810-7 contributor: fullname: Levine – volume: 103 start-page: 2070 year: 1996 ident: 10.1016/j.ophtha.2018.12.048_bib3 article-title: Central serous chorioretinopathy in younger and older adults publication-title: Ophthalmology doi: 10.1016/S0161-6420(96)30386-2 contributor: fullname: Spaide – volume: 152 start-page: 784 year: 2011 ident: 10.1016/j.ophtha.2018.12.048_bib9 article-title: A randomized pilot study of low-fluence photodynamic therapy versus intravitreal ranibizumab for chronic central serous chorioretinopathy publication-title: Am J Ophthalmol doi: 10.1016/j.ajo.2011.04.008 contributor: fullname: Bae – volume: 11 start-page: 39 year: 2017 ident: 10.1016/j.ophtha.2018.12.048_bib36 article-title: Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life publication-title: Clin Ophthalmol doi: 10.2147/OPTH.S115685 contributor: fullname: Breukink – volume: 103 start-page: 72 year: 1996 ident: 10.1016/j.ophtha.2018.12.048_bib44 article-title: Central serous chorioretinopathy in women publication-title: Ophthalmology doi: 10.1016/S0161-6420(96)30730-6 contributor: fullname: Quillen – volume: 123 start-page: 1751 year: 2016 ident: 10.1016/j.ophtha.2018.12.048_bib38 article-title: Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: the Comparison of Age-related macular degeneration Treatments Trials publication-title: Ophthalmology doi: 10.1016/j.ophtha.2016.03.045 contributor: fullname: Maguire – volume: 137 start-page: 496 year: 2004 ident: 10.1016/j.ophtha.2018.12.048_bib42 article-title: Choroidal neovascularization publication-title: Am J Ophthalmol doi: 10.1016/j.ajo.2003.09.042 contributor: fullname: Grossniklaus – volume: 109 start-page: 262 year: 2002 ident: 10.1016/j.ophtha.2018.12.048_bib43 article-title: Clinical characteristics of central serous chorioretinopathy in women publication-title: Ophthalmology doi: 10.1016/S0161-6420(01)00951-4 contributor: fullname: Perkins – volume: 35 start-page: 225 year: 2007 ident: 10.1016/j.ophtha.2018.12.048_bib14 article-title: Alterations of retinal pigment epithelium in central serous chorioretinopathy publication-title: Clin Exp Ophthalmol doi: 10.1111/j.1442-9071.2006.01447.x contributor: fullname: Hirami – volume: 91 start-page: 1554 year: 1984 ident: 10.1016/j.ophtha.2018.12.048_bib18 article-title: Peripheral retinal detachments and retinal pigment epithelial atrophic tracts secondary to central serous pigment epitheliopathy publication-title: Ophthalmology doi: 10.1016/S0161-6420(84)34117-3 contributor: fullname: Yannuzzi – year: 2012 ident: 10.1016/j.ophtha.2018.12.048_bib29 contributor: fullname: Gass – volume: 114 start-page: 2197 year: 2007 ident: 10.1016/j.ophtha.2018.12.048_bib39 article-title: Three-dimensional imaging of the foveal photoreceptor layer in central serous chorioretinopathy using high-speed optical coherence tomography publication-title: Ophthalmology doi: 10.1016/j.ophtha.2007.02.015 contributor: fullname: Ojima – volume: 166 start-page: 60 year: 2016 ident: 10.1016/j.ophtha.2018.12.048_bib20 article-title: Annular lesions and catenary forms in chronic central serous chorioretinopathy publication-title: Am J Ophthalmol doi: 10.1016/j.ajo.2016.03.025 contributor: fullname: Dansingani – volume: 112 start-page: 825 year: 2005 ident: 10.1016/j.ophtha.2018.12.048_bib23 article-title: Fundus autofluorescence and central serous chorioretinopathy publication-title: Ophthalmology doi: 10.1016/j.ophtha.2005.01.003 contributor: fullname: Spaide – volume: 133 start-page: 899 year: 2015 ident: 10.1016/j.ophtha.2018.12.048_bib41 article-title: Association of choroidal neovascularization and central serous chorioretinopathy with optical coherence tomography angiography publication-title: JAMA Ophthalmol doi: 10.1001/jamaophthalmol.2015.1320 contributor: fullname: Bonini Filho – volume: 159 start-page: 890 year: 2015 ident: 10.1016/j.ophtha.2018.12.048_bib31 article-title: Flat irregular retinal pigment epithelium detachments in chronic central serous chorioretinopathy and choroidal neovascularization publication-title: Am J Ophthalmol doi: 10.1016/j.ajo.2015.02.002 contributor: fullname: Hage – volume: 48 start-page: 82 year: 2015 ident: 10.1016/j.ophtha.2018.12.048_bib1 article-title: Central serous chorioretinopathy: recent findings and new physiopathology hypothesis publication-title: Prog Retin Eye Res doi: 10.1016/j.preteyeres.2015.05.003 contributor: fullname: Daruich – volume: 109 start-page: 1834 year: 2002 ident: 10.1016/j.ophtha.2018.12.048_bib11 article-title: Corticosteroids and central serous chorioretinopathy publication-title: Ophthalmology doi: 10.1016/S0161-6420(02)01117-X contributor: fullname: Carvalho-Recchia – volume: 111 start-page: 244 year: 2004 ident: 10.1016/j.ophtha.2018.12.048_bib2 article-title: Risk factors for central serous chorioretinopathy: a case-control study publication-title: Ophthalmology doi: 10.1016/j.ophtha.2003.09.024 contributor: fullname: Haimovici – volume: 68 start-page: 815 year: 1984 ident: 10.1016/j.ophtha.2018.12.048_bib4 article-title: Long-term follow-up of central serous chorioretinopathy publication-title: Br J Ophthalmol doi: 10.1136/bjo.68.11.815 contributor: fullname: Gilbert – volume: 12 year: 2017 ident: 10.1016/j.ophtha.2018.12.048_bib37 article-title: Long-term prognostic factors of chronic central serous chorioretinopathy after half-dose photodynamic therapy: a 3-year follow-up study publication-title: PLoS One doi: 10.1371/journal.pone.0181479 contributor: fullname: Haga – year: 2013 ident: 10.1016/j.ophtha.2018.12.048_bib34 contributor: fullname: Hosmer – volume: 35 start-page: 1360 year: 2015 ident: 10.1016/j.ophtha.2018.12.048_bib40 article-title: Choroidal neovascularization in Caucasian patients with longstanding central serous chorioretinopathy publication-title: Retina doi: 10.1097/IAE.0000000000000529 contributor: fullname: Peiretti – volume: 84 start-page: 799 year: 1986 ident: 10.1016/j.ophtha.2018.12.048_bib13 article-title: Type A behavior and central serous chorioretinopathy publication-title: Trans Am Ophthalmol Soc contributor: fullname: Yannuzzi – volume: 79 start-page: 417 year: 2001 ident: 10.1016/j.ophtha.2018.12.048_bib7 article-title: Long-term follow-up of idiopathic central serous chorioretinopathy without laser publication-title: Acta Ophthalmol Scand doi: 10.1034/j.1600-0420.2001.079004417.x contributor: fullname: Bujarborua – volume: 27 start-page: 1168 year: 2007 ident: 10.1016/j.ophtha.2018.12.048_bib15 article-title: The natural history of pigment epithelial detachment associated with central serous chorioretinopathy publication-title: Retina doi: 10.1097/IAE.0b013e318156db8a contributor: fullname: Mudvari – volume: 123 start-page: 1541 year: 2016 ident: 10.1016/j.ophtha.2018.12.048_bib19 article-title: Bullous variant of central serous chorioretinopathy: expansion of phenotypic features using multimethod imaging publication-title: Ophthalmology doi: 10.1016/j.ophtha.2016.03.017 contributor: fullname: Balaratnasingam – volume: 28 start-page: 201 year: 2008 ident: 10.1016/j.ophtha.2018.12.048_bib27 article-title: Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation publication-title: Retina doi: 10.1097/IAE.0b013e3181669504 contributor: fullname: Freund – volume: 30 start-page: 1333 year: 2010 ident: 10.1016/j.ophtha.2018.12.048_bib28 article-title: Do we need a new classification for choroidal neovascularization in age-related macular degeneration? publication-title: Retina doi: 10.1097/IAE.0b013e3181e7976b contributor: fullname: Freund – volume: 115 start-page: 1494 year: 2008 ident: 10.1016/j.ophtha.2018.12.048_bib10 article-title: Morphologic changes in acute central serous chorioretinopathy evaluated by Fourier-domain optical coherence tomography publication-title: Ophthalmology doi: 10.1016/j.ophtha.2008.01.021 contributor: fullname: Fujimoto – volume: 22 start-page: 19 year: 2002 ident: 10.1016/j.ophtha.2018.12.048_bib6 article-title: Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy publication-title: Retina doi: 10.1097/00006982-200202000-00004 contributor: fullname: Loo – volume: 36 start-page: 499 year: 2016 ident: 10.1016/j.ophtha.2018.12.048_bib16 article-title: En face imaging of pachychoroid spectrum disorders with swept-source optical coherence tomography publication-title: Retina doi: 10.1097/IAE.0000000000000742 contributor: fullname: Dansingani – volume: 115 start-page: 169 year: 2008 ident: 10.1016/j.ophtha.2018.12.048_bib35 article-title: The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002 publication-title: Ophthalmology doi: 10.1016/j.ophtha.2007.02.032 contributor: fullname: Kitzmann – volume: 24 start-page: 130 year: 2017 ident: 10.1016/j.ophtha.2018.12.048_bib33 article-title: Tutorial on biostatistics: linear regression analysis of continuous correlated eye data publication-title: Ophthalmic Epidemiol doi: 10.1080/09286586.2016.1259636 contributor: fullname: Ying – volume: 32 start-page: 1829 year: 2012 ident: 10.1016/j.ophtha.2018.12.048_bib24 article-title: Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration publication-title: Retina doi: 10.1097/IAE.0b013e3182680a66 contributor: fullname: Fung – volume: 23 start-page: 1 year: 2003 ident: 10.1016/j.ophtha.2018.12.048_bib25 article-title: Cystoid macular degeneration in chronic central serous chorioretinopathy publication-title: Retina doi: 10.1097/00006982-200302000-00001 contributor: fullname: Iida – volume: 33 start-page: 1735 year: 2013 ident: 10.1016/j.ophtha.2018.12.048_bib8 article-title: Multimodal imaging of pigment epithelial detachment: a guide to evaluation publication-title: Retina doi: 10.1097/IAE.0b013e3182993f66 contributor: fullname: Mrejen – volume: 8 year: 2013 ident: 10.1016/j.ophtha.2018.12.048_bib12 article-title: Epidemiology of idiopathic central serous chorioretinopathy in Taiwan, 2001-2006: a population-based study publication-title: PLoS One contributor: fullname: Tsai – volume: 35 start-page: 1 year: 2015 ident: 10.1016/j.ophtha.2018.12.048_bib26 article-title: Pachychoroid neovasculopathy publication-title: Retina doi: 10.1097/IAE.0000000000000331 contributor: fullname: Pang – volume: 83 start-page: 161 year: 2005 ident: 10.1016/j.ophtha.2018.12.048_bib32 article-title: Fundus autofluorescence in acute and chronic-recurrent central serous chorioretinopathy publication-title: Acta Ophthalmol Scand doi: 10.1111/j.1600-0420.2005.00442.x contributor: fullname: Framme |
SSID | ssj0006634 |
Score | 2.661961 |
Snippet | To evaluate the long-term visual outcomes and causes of vision loss in chronic central serous chorioretinopathy (CSC).
Retrospective, longitudinal study.
A... PURPOSETo evaluate the long-term visual outcomes and causes of vision loss in chronic central serous chorioretinopathy (CSC). DESIGNRetrospective, longitudinal... |
SourceID | hal proquest crossref pubmed elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 576 |
SubjectTerms | Adult Aged Aged, 80 and over Central Serous Chorioretinopathy - complications Central Serous Chorioretinopathy - diagnostic imaging Central Serous Chorioretinopathy - physiopathology Choroidal Neovascularization - etiology Choroidal Neovascularization - physiopathology Chronic Disease Coloring Agents - administration & dosage Female Fluorescein Angiography Humans Indocyanine Green - administration & dosage Life Sciences Longitudinal Studies Macular Edema - etiology Macular Edema - physiopathology Male Middle Aged Multimodal Imaging Optical Imaging Photography Retinal Degeneration - etiology Retinal Degeneration - physiopathology Retrospective Studies Vision Disorders - diagnostic imaging Vision Disorders - etiology Vision Disorders - physiopathology Visual Acuity - physiology |
Title | Long-term Visual Outcomes and Causes of Vision Loss in Chronic Central Serous Chorioretinopathy |
URI | https://dx.doi.org/10.1016/j.ophtha.2018.12.048 https://www.ncbi.nlm.nih.gov/pubmed/30659849 https://search.proquest.com/docview/2179404137 https://hal.science/hal-03486015 |
Volume | 126 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdpCmMvY9_LvtDG3oqDbEt2_JiFlrAmDYyky5uQbblJ1tkldfawh_3tu7Nkz6Er6_ZigsAy3P1ydzr97o6QD8ivgWNB6Cg3YQ5XvnAGqY6cIIuzIOBxoKsb0-lZMF7wT0ux7HR-tqtLyrif_PhjXcn_aBXWQK9YJfsPmm02hQX4DfqFJ2gYnnfS8aTILxy0rUfn62usA5ntSviONn2XR2p3bVrKnlcF5EcTcIhVlZ9piFtndtFeIBF2tCq266qqMS9wUPHehe_salWu1OU307KpyjvYUVuGfJ_n_VZSYbrVG2PP9jLOH9UldhrPFSYoDBKxuiHdqq_I9G6Mv7LGcI5JmDalEUna6726nHbWwo1aZBdtLS2PHPCM_p4pNtXzFnO8ZVhFGLR8tDCjAG-Yf5OJ2PSLSiZI3BtUyV7TzHO_2_bZTJ4sJhM5P17OD8ihF0ZCdMnh8PTzl9PGl0M8xuuCy4oVeHPn2wKagxUya287tlThy_wheWDPHXRoQPSIdHT-mNybWmbFEyIbLFGDJVpjiYKcqcESLTJqsEQRS3SdU4slarFEDZboDSw9JYuT4_lo7NjhG04CMXvpqMhLXDfLuB8mIuJM-7HiEA0qD9wni_w01GKg00hnCgTHkpClnCccTv9hmsAxwH9GunmR6xeEMgjEVBwlirGYc8-LstDNRDZgWqSZVkGPOLUE5ZXpsSJr8uFGGolLlLh0PQkS75GwFrO0caKJ_yTg4C9vvgetNB_B1urj4UTiGvNxHJsrvrs98q5WmgRbixdoKtcgO-mh92IQ9oU98txos9nLR4LCgEcv7_D2K3L_93_iNemW251-A7FtGb-1APwFcNqpsQ |
link.rule.ids | 230,315,786,790,891,27955,27956 |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Long-term+Visual+Outcomes+and+Causes+of+Vision+Loss+in+Chronic+Central+Serous+Chorioretinopathy&rft.jtitle=Ophthalmology+%28Rochester%2C+Minn.%29&rft.au=Mrejen%2C+Sarah&rft.au=Balaratnasingam%2C+Chandrakumar&rft.au=Kaden%2C+Talia+R&rft.au=Bottini%2C+Alexander&rft.date=2019-04-01&rft.eissn=1549-4713&rft.volume=126&rft.issue=4&rft.spage=576&rft.epage=588&rft_id=info:doi/10.1016%2Fj.ophtha.2018.12.048&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0161-6420&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0161-6420&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0161-6420&client=summon |